Volume 64, Number 1, 95-97, DOI: 10.1007/BF00427352

Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness

A. Coppen, V. A. Rama Rao, C. R. J. Ruthven, B. L. Goodwin and M. Sandler

View Related Documents

Abstract

The urinary excretion of 4-hydroxy-3-methoxyphenyglycol was compared in a group of 23 depressive patients and 27 control subjects of similar age. There was no difference between patients and controls although female controls excreted less than males. After 6 weeks' treatment with 150 mg daily of amitriptyline there was no correlation between therapeutic response and pretreatment urinary excretion value.

Key words  Depressive illness - Noradrenaline hypothesis - Amitriptyline - 4-Hydroxy-3-methoxyphenylglycol

Fulltext Preview

Image of the first page of the fulltext document